Robert Sidonio Jr
- Department of Pediatrics
Associate Professor
- (404) 785-1637
- robert.sidonio.jr@emory.edu
- Children's Healthcare of Atlanta
-
Aflac Cancer and Blood Disorders Center
Pediatrics
1760 Haygood Drive
Overview
I am a clinical researcher focused on women and girls with bleeding disorders and the care for hemophilia A patients with inhibitors. I am currently the PI of multiple national and international investigator initiated studies including the MOTIVATE study, Emi PUPs and Nuwiq ITI study, ATHN 9 and the Mexico Inhibitor Study.
Academic Appointment
- Associate Professor of Pediatrics, Emory University
Education
Degrees
- MD from University of Alabama at Birmingham
- BS from Troy University
Research
Publications
-
The sweet business of VWF clearance.
Blood Volume: 145 Page(s): 2680 - 2681
06/05/2025 Authors: Li R; Sidonio RF -
Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease.
AJOG Glob Rep Volume: 5 Page(s): 100501
05/01/2025 Authors: Kiss C; Boda Z; Khayat CD; Boban A; Dubey L; Sidonio RF -
Bone Health Screening in Persons With Bleeding Disorders: A Survey of United States Haemophilia Treatment Centres.
Haemophilia Volume: 31 Page(s): 519 - 525
05/01/2025 Authors: Citla-Sridhar D; Ahuja S; Sidonio R; Chitlur M; Sharathkumar A; Tobase P; Acharya S; Isaac D; Kulkarni R; Johnson MM -
Development of a Structured Management Plan and Educational Materials for a Multidisciplinary Pediatric Menstrual Bleeding Disorder Clinic.
J Dr Nurs Pract
04/10/2025 Authors: Tickle K; Hartley P; Langley-Brady D; Joshua T; Sidonio RF; Brown M; Gettis M; Cherven B -
Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature.
J Thromb Haemost Volume: 23 Page(s): 863 - 876
03/01/2025 Authors: Comishen KJ; Bhatt M; Yeung K; Irfan J; Zia A; Sidonio RF; James P -
Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis.
Res Pract Thromb Haemost Volume: 9 Page(s): 102719
02/01/2025 Authors: Sidonio RF; Dubey L; Vilchevska KV; Inati A; Djambas Khayat C -
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.
J Thromb Haemost Volume: 23 Page(s): 651 - 656
02/01/2025 Authors: Goldenberg NA; Schulman S; Kittelson JM; Abshire TC; Casella JF; Dale R; Halperin JL; Hanson J; Kessler CM; Manco-Johnson MJ -
Real-world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi-institutional case series.
Haemophilia Volume: 30 Page(s): 1321 - 1331
11/01/2024 Authors: Youkhana K; Batsuli G; Acharya S; Khan O; Tran DQ; Dvorak A; Recht M; Young G; Sidonio R; Abajas Y -
Factor VIII stimulants and other novel therapies for the treatment of von Willebrand disease: what's new on the horizon?
Expert Opin Pharmacother Volume: 25 Page(s): 1427 - 1438
08/01/2024 Authors: Regling K; Sidonio RF -
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH.
J Thromb Haemost Volume: 22 Page(s): 2059 - 2070
07/01/2024 Authors: Baker RI; Choi P; Curry N; Gebhart J; Gomez K; Henskens Y; Heubel-Moenen F; James P; Kadir RA; Kouides P